CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
41.93
-0.52 (-1.22%)
At close: Jan 8, 2026, 4:00 PM EST
42.01
+0.08 (0.19%)
After-hours: Jan 8, 2026, 7:05 PM EST
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $3.38 billion as of January 8, 2026. Its market cap has increased by 58.56% in one year.
Market Cap
3.38B
Enterprise Value
2.71B
1-Year Change
58.56%
Ranking
Category
Stock Price
$41.93
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $3.38B, an increase of 180.42%. That is a compound annual growth rate of 69.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 3.42B | 2.24% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |